TrialBone marrow transplantation2016

Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study.

M van Gelder et al.PubMed ↗Publisher ↗

No numbers read from the abstract.